Home

التعبير يرفق الى يتصعد claude bertrand servier أسقف تدريس روحي الصفحة

Pose de la première pierre du nouvel Institut de recherche de Servier à  Paris-Saclay - Etablissement public d'aménagement Paris-Saclay (EPAPS)
Pose de la première pierre du nouvel Institut de recherche de Servier à Paris-Saclay - Etablissement public d'aménagement Paris-Saclay (EPAPS)

Mediator : la face cachée de Jacques Servier
Mediator : la face cachée de Jacques Servier

MaaT Pharma Appoints Claude Bertrand, Servier's Executive Vice President of  R&D, as Independent Board Member and Welcomes New Chief Medical Officer  John Weinberg | Business Wire
MaaT Pharma Appoints Claude Bertrand, Servier's Executive Vice President of R&D, as Independent Board Member and Welcomes New Chief Medical Officer John Weinberg | Business Wire

Claude Bertrand - United Kingdom | Professional Profile | LinkedIn
Claude Bertrand - United Kingdom | Professional Profile | LinkedIn

Our Team - Abivax
Our Team - Abivax

SERVIER : DES ALLIANCES PLUS RENTABLES - Biotech Finances
SERVIER : DES ALLIANCES PLUS RENTABLES - Biotech Finances

Ivosidenib/Azacitidine Significantly Improves EFS in Previously Untreated  IDH1-Mutated AML
Ivosidenib/Azacitidine Significantly Improves EFS in Previously Untreated IDH1-Mutated AML

Intervention Claude Bertrand - Journée Responsable - YouTube
Intervention Claude Bertrand - Journée Responsable - YouTube

Board of Directors - Symphogen
Board of Directors - Symphogen

Claude Bertrand - Scientific Advisor at Abivax | The Org
Claude Bertrand - Scientific Advisor at Abivax | The Org

Dr Claude Bertrand, General Director of Research and Development at Servier  - Servier
Dr Claude Bertrand, General Director of Research and Development at Servier - Servier

Frédéric VIGNERON - Industrial Excellence Consultant - Servier | LinkedIn
Frédéric VIGNERON - Industrial Excellence Consultant - Servier | LinkedIn

News
News

Servier (@Servier) / Twitter
Servier (@Servier) / Twitter

Servier transforme sa R&D pour répondre à l'objectif de lancer...
Servier transforme sa R&D pour répondre à l'objectif de lancer...

Our Team - Abivax
Our Team - Abivax

1 2-3 4-5 6-7 8-9 10-11 12-13 14-15 16-17 18-19 20-21 22-23 24-25 26-27  28-29 30-31 32 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Close Cookies  management panel When you visit the “servier.com” website, cookies are  placed on your browser. Your ...
1 2-3 4-5 6-7 8-9 10-11 12-13 14-15 16-17 18-19 20-21 22-23 24-25 26-27 28-29 30-31 32 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Close Cookies management panel When you visit the “servier.com” website, cookies are placed on your browser. Your ...

pirs12312019ex1016
pirs12312019ex1016

Servier Announces Positive Topline Data from the Global Phase 3 Study of  TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine in Patients  with Previously Untreated IDH1-mutated Acute Myeloid Leukemia
Servier Announces Positive Topline Data from the Global Phase 3 Study of TIBSOVO® (ivosidenib tablets) in Combination with Azacitidine in Patients with Previously Untreated IDH1-mutated Acute Myeloid Leukemia

Claude Bertrand - United Kingdom | Professional Profile | LinkedIn
Claude Bertrand - United Kingdom | Professional Profile | LinkedIn

Servier backs an American startup at LabCentral in the
Servier backs an American startup at LabCentral in the

Claude Bertrand's email & phone | Servier's Executive Vice President R and  D, Chief Scientific Officer email
Claude Bertrand's email & phone | Servier's Executive Vice President R and D, Chief Scientific Officer email

Claude Bertrand's email & phone | Servier's Executive Vice President R and  D, Chief Scientific Officer email
Claude Bertrand's email & phone | Servier's Executive Vice President R and D, Chief Scientific Officer email

French pharma company Servier tabs Montreal for new AI hub
French pharma company Servier tabs Montreal for new AI hub

Servier on Twitter: "We are always exploring different ways to serve  patients' needs. This includes #research & #development of monoclonal  antibodies to fight against #cancer. Learn more about our latest  announcements👉https://t.co/Q84thhbOsh https://t ...
Servier on Twitter: "We are always exploring different ways to serve patients' needs. This includes #research & #development of monoclonal antibodies to fight against #cancer. Learn more about our latest announcements👉https://t.co/Q84thhbOsh https://t ...

Claude Bertrand's email & phone | Servier's Executive Vice President R and  D, Chief Scientific Officer email
Claude Bertrand's email & phone | Servier's Executive Vice President R and D, Chief Scientific Officer email